Navigation Links
Mirixa Corporation Announces Key New Hires
Date:7/9/2009

RESTON, Va., July 9 /PRNewswire/ -- Mirixa Corporation, the leader in targeted pharmacy-based patient care services, today announced the hiring of three new members to its growing pharmacy team. Mirixa welcomes Joseph Gruber, RPh, CGP, FASCP, Kim Swiger, RPh, and Paul Miller, MS, RPh.

Each new team member will work closely with Mirixa's pharmacy partners, state and national pharmacy associations, national standards groups, and patient program sponsors to continue the development of new innovative programs.

"These three industry-recognized pharmacists bring to Mirixa many years of experience in patient care and clinical program management, and we're delighted to have them on the Mirixa team," said Rick Solano, Mirixa's chief executive officer.

Joseph Gruber has a strong focus in long term care, and has previously served in senior roles at Omnicare, Inc., The Jewish Hospital of St. Louis, and most recently as President/CEO of ASCP Ventures, Inc., a subsidiary of the American Society of Consultant Pharmacists. Mr. Gruber has published several articles on geriatric pharmacotherapy and disease and medication management. He has been recognized for numerous industry awards including the Commission for Certification in Geriatric Pharmacy (CCGP) Excellence in Geriatric Pharmacy Practice Award.

Kim Swiger will focus her years of clinical experience on developing programs for, and on behalf of, the schools of pharmacy and state pharmacy associations. Prior to joining Mirixa, Ms. Swiger was responsible for implementation of MTM services, continuous quality improvement and corporate pharmacy operations for Ukrop's Super Markets, Inc.

Paul Miller brings to Mirixa vast experience, both nationally and internationally, in clinical research and pharmacy practice management. Prior to joining Mirixa, Mr. Miller held prominent positions at Mayo Medical Center and numerous well-known hospitals in the U.S. and abroad. As the Project Director for Health Care Reform, Mr. Miller led a team of medical professionals responsible for improving the primary health care system of Romania. He continues to be involved in pharmacy related humanitarian efforts throughout the world.

About Mirixa

Mirixa Corporation, sponsored by the National Community Pharmacists Association (NCPA), is the leader in targeted patient care services delivered via the nation's largest pharmacy-based patient care network. Dedicated to improving patients' health, Mirixa enables the healthcare community to deliver patient care services through retail pharmacy. The MirixaPro(SM) web-based clinical platform is used by pharmacists to deliver standardized patient care services. For more information, please visit www.Mirixa.com.

    Contact:  Barbara Byrne
              703.865.2028
              PR@Mirixa.com


'/>"/>
SOURCE Mirixa Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Mirixa Corporation and the APhA Foundation Form Partnership
2. Mirixa Announces Agreement With the Pharmacy Guild of Australia
3. Mirixa Corporation and the APhA Foundation Finalize Partnership
4. Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue
5. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
6. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
7. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
8. BioElectronics Corporation Announces Singapore and Malaysia Sales
9. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
10. DURECT Corporation to Present at the NewsMakers in the Biotech Industry Investment Conference
11. Insulet Corporation to Present at the Thomas Weisel Partners Healthcare Conference on September 6, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... LEXINGTON, Massachusetts , February 4, 2016 - New ... --> - New FDA action date of July ... date of July 22, 2016   - ... the U.S. in the past decade indicated for the treatment of signs and ... Lifitegrast has the potential to be the only product approved in the ...
(Date:2/4/2016)... 4, 2016  CytoSorbents Corporation (NASDAQ: CTSO ... flagship CytoSorb® blood filter to treat deadly inflammation ... world, announced that CEO Dr. Phillip Chan ... Capital Group,s 2016 Disruptive Growth & Healthcare Conference, ... Conference Presentation Details: Where: Convene ...
(Date:2/4/2016)... Feb. 4, 2016 Sinovac Biotech Ltd. ("Sinovac" ... provider of biopharmaceutical products in China ... board of directors received on February 4, 2016 a ... a consortium comprised of PKU V-Ming ( Shanghai ... Ltd., CICC Qianhai Development ( Shenzhen ) ...
(Date:2/3/2016)... 2016  Discovery Laboratories, Inc. (NASDAQ: DSCO ... KL4 surfactant therapies for respiratory diseases, today announced ... inducement award as a component of employment compensation ... President and Chief Executive Officer.  The award was ... 1, 2016 and granted as an inducement material ...
Breaking Biology Technology:
(Date:2/3/2016)... , February 3, 2016 ... market research report "Automated Fingerprint Identification System Market by ... Search), Application (Banking & Finance, Government, Healthcare, and Transportation) ... MarketsandMarkets, the market is expected to be worth USD ... 21.0% between 2015 and 2020. The transformation and technology ...
(Date:2/2/2016)... 2016  BioMEMS devices deployed in hospitals ... medical screening and diagnostic applications, such as ... that facilitate and assure continuous monitoring without ... being bolstered through new opportunities offered by ... coupled with wireless connectivity and low power ...
(Date:2/2/2016)... YORK , Feb. 2, 2016 Technology Enhancements ... presents an analysis of the digital and computed radiography ... Malaysia , and Indonesia ... trends and market size, as well as regional market ... country and discusses market penetration and market attractiveness, both ...
Breaking Biology News(10 mins):